Table 1 Clinical and demographic data of the cohort (n = 57)
From: Onset of lupus like syndrome in patients with spondyloarthritis treated with anti-TNF-α
Characteristics | N = 57 (% or range) |
|---|---|
Male/Female (%) | 39/18 (68.4/31.6) |
Mean Age (range) | 41.2 (23-66) |
Type of Spondyloarthritis (%) | |
Ankylosing Spondylitis | 8 (14) |
Reactive arthritis | 16 (28) |
Undiffenciated Spondyloarthritis | 22 (38.6) |
Psoriatic arthritis | 7 (12.3) |
Enteropathic artritis | 4 (7.1) |
Patients treated with IFX (%) | 28 (49.1) |
Patients treated with ADA (%) | 19 (33.3) |
Patients treated with ETP (%) | 10 (17.6) |
Mean duration of therapy with IFX in months (range) | 18 (1-78) |
Mean duration of therapy with ADA in months (range) | 13 (1-88) |
Mean duration of therapy with ETP in months (range) | 7 (1-38) |
ANA positive (%) | 4 (7.01) |
Anti dsDNA (%) | 2 (3.5) |
Moderate lupus-like symptoms (%) | 0 |
Severe lupus-like symptoms (%) | 1 |